Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 15, 2018
Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions"Gabrielle Macaron, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2020
Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosisMartina Absinta, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2019
MS progression is predominantly driven by age-related mechanisms - NOMarisa McGinley, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2020
Detection of central vein should be part of MS diagnostic criteria - YesNikos Evangelou, Daniel Ontaneda
Biomedicines|November 27, 2025
Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald CriteriaAmjad Samara, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Breaking Barriers in Multiple SclerosisDaniel Ontaneda, Veronique E Miron
CNS Drugs|September 27, 2015
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisAdnan M Subei, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2016
Propensity methods for multiple sclerosis: The devil is in the detailsDaniel Ontaneda, Thomas E Love
JAMA Neurology|June 16, 2020
Keep the Worms in the MudDaniel Ontaneda, Jeffrey A Cohen
Neurology|March 4, 2025
To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis DiagnosisAngela Vidal-Jordana, Daniel Ontaneda
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 15, 2018
Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions"Gabrielle Macaron, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2020
Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosisMartina Absinta, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2019
MS progression is predominantly driven by age-related mechanisms - NOMarisa McGinley, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2020
Detection of central vein should be part of MS diagnostic criteria - YesNikos Evangelou, Daniel Ontaneda
Biomedicines|November 27, 2025
Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald CriteriaAmjad Samara, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Breaking Barriers in Multiple SclerosisDaniel Ontaneda, Veronique E Miron
CNS Drugs|September 27, 2015
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisAdnan M Subei, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2016
Propensity methods for multiple sclerosis: The devil is in the detailsDaniel Ontaneda, Thomas E Love
JAMA Neurology|June 16, 2020
Keep the Worms in the MudDaniel Ontaneda, Jeffrey A Cohen
Neurology|March 4, 2025
To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis DiagnosisAngela Vidal-Jordana, Daniel Ontaneda
Pageof 20